Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
- Authors
- Park, Soo-Kyung; Choi, Chang Hwan; Chun, Jaeyoung; Lee, Heeyoung; Kim, Eun Sun; Park, Jae Jun; Park, Chan Hyuk; Lee, Bo-In; Jung, Yunho; Park, Dong-Il; Kim, Do Young; Park, Hana; Jeen, Yoon Tae
- Issue Date
- 1월-2020
- Publisher
- KOREAN ASSOC STUDY INTESTINAL DISEASES
- Keywords
- Inflammatory bowel disease; Viral hepatitis; Vaccination; Prevention
- Citation
- INTESTINAL RESEARCH, v.18, no.1, pp.18 - 33
- Indexed
- SCOPUS
KCI
- Journal Title
- INTESTINAL RESEARCH
- Volume
- 18
- Number
- 1
- Start Page
- 18
- End Page
- 33
- ISSN
- 1598-9100
- Abstract
- The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host's immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.